Tuesday, July 30, 2013 8:45:42 PM
I am not sure we are going to get a response in any regard to the Novell settlement. The NDA can be the company answer and there isn't a lot that can be done. First I am reasonably certain that a settlement did occur. If it did not I would just expect the case to be dragged all the way to the Markman as there would be no harm in letting it proceed at that level if the parties didn't want to settle. The question then becomes "investor expectation" vs "company expectations". If the street is willing to take 1% from FB but not less than 5% from Novell then what is the value of actually putting anything out? We (investment community), try to equate things to bottom line numbers and I am not sure there will ever be a 100% consensus on any given settlement. I cannot get the thought out of my head that this was a legal necessity. Just for appearances, a settlement with a larger CRM company like Novell is very important. Salesforce is in the same league and I just can't help but think this has something to do with that. Since it was dismissed with prejuduice that means that they can go back later and take another bite of the apple. There are many more here that can discuss that. They got something and I am pretty confident we will be able to find it somehow in 3Q numbers as long as we can break apart BVSN and JIVE Qs. I still believe that current PPS is mainly due to Dilution+Institution sales post merger. I cannot get to crazy with management as they have only been in place for 27 days. I think I am just hoping that Markman stays on schedule and we get an acquisition on board. Not really sure what other catalysts in the short term. I just have a feeling that there is more than meets the eye regarding not putting an 8K out regarding settlement.
Recent DSS News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/09/2024 09:15:31 PM
- Impact Biomedical, Inc. Announces U.S. Patent Allowance of Laetose™ Technology Entitled "Low Glycemic Sugar Composition." • GlobeNewswire Inc. • 01/30/2024 01:05:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 09:54:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 09:05:40 PM
- DSS, Inc. Chairman Chan Acquires 672,173 shares of DSS In Open Market • GlobeNewswire Inc. • 01/04/2024 01:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2024 09:15:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2024 02:10:36 PM
- DSS, Inc. Announces Reverse Split as Part of NYSE American Compliance Plan • GlobeNewswire Inc. • 12/22/2023 09:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/18/2023 09:30:23 PM
- Form DEF 14C - Other definitive information statements • Edgar (US Regulatory) • 12/13/2023 09:15:25 PM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 12/01/2023 09:15:06 PM
- Premier Packaging, a Wholly-Owned Subsidiary of DSS, Inc., Secures Contract Extension with Major Retailer Worth Up to $15 Million over Four Years • GlobeNewswire Inc. • 11/28/2023 01:10:00 PM
- DSS Inc. Wins Patent Dispute with Nichia Corporation • GlobeNewswire Inc. • 11/14/2023 01:00:00 PM
- DSS, Inc. Subsidiary Files Current Report on Form 8-K Disclosing Reverse Split of Outstanding and Issued Common Stock and Conversion of Certain Holder’s Common Stock • GlobeNewswire Inc. • 11/08/2023 01:31:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/27/2023 08:05:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/26/2023 09:25:10 PM
- DSS Inc. Receives Notice of Non-Compliance with NYSE American Trading Share Price Listing Rule • GlobeNewswire Inc. • 10/26/2023 09:25:00 PM
- DSS, Inc. Announces Filing of Registration Statement on Form S-1 for Initial Public Offering of Impact Biomedical • GlobeNewswire Inc. • 10/23/2023 12:25:00 PM
- DSS Inc. Issues Letter to Shareholders • GlobeNewswire Inc. • 10/12/2023 12:25:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 10/03/2023 08:31:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/03/2023 08:30:13 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 09/12/2023 08:30:20 PM
- DSS Inc. Expands DSS Wealth Management, Inc.'s Management Team for Ramp Up of Asset Management Subsidiary • GlobeNewswire Inc. • 09/06/2023 12:40:00 PM
- DSS Inc. Announces Distribution Date of August 8, 2023 for Spinoff of Impact BioMedical Inc. • GlobeNewswire Inc. • 07/31/2023 12:15:00 PM
- DSS Inc. Appoints Daniel Lew as Chief Investment Officer and Portfolio Manager for DSS Wealth, Inc. • GlobeNewswire Inc. • 07/05/2023 12:15:00 PM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM